Pirenperone
Pirenperone is an antipsychotic drug that was developed in the 1970s. It is classified as an atypical antipsychotic due to its unique pharmacological properties. Pirenperone has been studied for its potential use in the treatment of schizophrenia, but it has not been widely adopted in clinical practice.
Pharmacology[edit | edit source]
Pirenperone acts as an antagonist at the D2 dopamine receptor and the 5-HT2A serotonin receptor, which are both implicated in the pathophysiology of schizophrenia. It also has affinity for the H1 histamine receptor and the alpha-1 adrenergic receptor, which may contribute to its side effect profile.
Clinical Use[edit | edit source]
While pirenperone has been studied in clinical trials for the treatment of schizophrenia, it has not been widely adopted in clinical practice. The reasons for this are not entirely clear, but may relate to its side effect profile or lack of clear superiority over other available antipsychotic drugs.
Side Effects[edit | edit source]
Like many antipsychotic drugs, pirenperone can cause a range of side effects. These may include sedation, orthostatic hypotension, and anticholinergic effects such as dry mouth and constipation. It may also cause extrapyramidal symptoms such as tremor and rigidity, although these are generally less common with atypical antipsychotics like pirenperone than with older, typical antipsychotics.
See Also[edit | edit source]
- Atypical antipsychotic
- Dopamine receptor D2
- Serotonin receptor 5-HT2A
- Histamine receptor H1
- Alpha-1 adrenergic receptor
Pirenperone Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD